Instil Bio, Inc. expected to post a loss of 17 cents a share - Earnings Preview
Instil Bio, Inc. TIL.O is expected to report results on November 11 (estimated) for the period ending September 30 2026
LSEG's mean analyst estimate for Instil Bio, Inc. is for a loss of 17 cents per share.
The one available analyst rating on the shares is "hold".
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Instil Bio, Inc. is $7.00, about 2.5% above its last closing price of $6.83
This summary was machine generated November 9 at 13:47 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)